These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18942275)

  • 1. Differences in lower urinary tract symptoms, treatment and mortality among African-American and white elderly men.
    Howard DL; Taylor YJ; Ross LE
    J Natl Med Assoc; 2008 Oct; 100(10):1146-52. PubMed ID: 18942275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of lower urinary tract symptom severity and associated bother between community-dwelling black and white men: the Olmsted County Study of Urinary Symptoms and Health Status and the Flint Men's Health Study.
    Sarma AV; Wei JT; Jacobson DJ; Dunn RL; Roberts RO; Girman CJ; Lieber MM; Cooney KA; Schottenfeld D; Montie JE; Jacobsen SJ; ;
    Urology; 2003 Jun; 61(6):1086-91. PubMed ID: 12809866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare practices among blacks and whites with urinary tract symptoms.
    Howard DL; Edwards BG; Whitehead K; Amamoo MA; Godley PA
    J Natl Med Assoc; 2007 Apr; 99(4):404-11. PubMed ID: 17444430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes treatment and progression of benign prostatic hyperplasia in community-dwelling black and white men.
    Sarma AV; St Sauver JL; Hollingsworth JM; Jacobson DJ; McGree ME; Dunn RL; Lieber MM; Jacobsen SJ;
    Urology; 2012 Jan; 79(1):102-8. PubMed ID: 22112286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign prostatic hyperplasia: racial differences in treatment patterns and prostate cancer prevalence.
    Pettaway CA; Lamerato LE; Eaddy MT; Edwards JK; Hogue SL; Crane MM
    BJU Int; 2011 Oct; 108(8):1302-8. PubMed ID: 21371244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between diabetes and clinical markers of benign prostatic hyperplasia among community-dwelling Black and White men.
    Sarma AV; Burke JP; Jacobson DJ; McGree ME; St Sauver J; Girman CJ; Lieber MM; Herman W; Macoska J; Montie JE; Jacobsen SJ
    Diabetes Care; 2008 Mar; 31(3):476-82. PubMed ID: 18071006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment options, selection, and satisfaction among African American and white men with prostate carcinoma in North Carolina.
    Demark-Wahnefried W; Schildkraut JM; Iselin CE; Conlisk E; Kavee A; Aldrich TE; Lengerich EJ; Walther PJ; Paulson DF
    Cancer; 1998 Jul; 83(2):320-30. PubMed ID: 9669815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Prostate Size Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from the REDUCE Trial.
    Simon RM; Howard LE; Moreira DM; Roehrborn C; Vidal AC; Castro-Santamaria R; Freedland SJ
    Eur Urol; 2016 May; 69(5):885-91. PubMed ID: 26724841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal changes in lower urinary tract symptoms among a cohort of black American men: the Flint Men's Health Study.
    Sarma AV; McLaughlin JC; Jacobsen SJ; Logie J; Dolin P; Dunn RL; Cooney KA; Montie JE; Schottenfeld D; Wei JT
    Urology; 2004 Nov; 64(5):959-65. PubMed ID: 15533486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between socioeconomic status (SES) and lower urinary tract symptom (LUTS) severity among black and white men.
    Fowke JH; Munro H; Signorello LB; Blot WJ; Penson DF;
    J Gen Intern Med; 2011 Nov; 26(11):1305-10. PubMed ID: 21720905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of BPH and lower urinary tract symptoms in West Africans.
    Chokkalingam AP; Yeboah ED; Demarzo A; Netto G; Yu K; Biritwum RB; Tettey Y; Adjei A; Jadallah S; Li Y; Chu LW; Chia D; Niwa S; Partin A; Thompson IM; Roehrborn C; Hoover RN; Hsing AW
    Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):170-6. PubMed ID: 21912428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Men's theories about benign prostatic hyperplasia and prostate cancer following a benign prostatic hyperplasia decision aid.
    Holmes-Rovner M; Price C; Rovner DR; Kelly-Blake K; Lillie J; Wills C; Bonham VL
    J Gen Intern Med; 2006 Jan; 21(1):56-60. PubMed ID: 16423124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.
    Jin R; Strand DW; Forbes CM; Case T; Cates JMM; Liu Q; Ramirez-Solano M; Milne GL; Sanchez S; Wang ZY; Bjorling DE; Miller NL; Matusik RJ
    Prostate; 2021 Sep; 81(13):944-955. PubMed ID: 34288015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
    Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
    JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE.
    Moses KA; Paciorek AT; Penson DF; Carroll PR; Master VA
    J Clin Oncol; 2010 Feb; 28(6):1069-74. PubMed ID: 20100957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial differences in the treatment and outcomes for prostate cancer in Massachusetts.
    Cole AP; Herzog P; Iyer HS; Marchese M; Mahal BA; Lipsitz SR; Nyambose J; Gershman ST; Kennedy M; Merriam G; Rebbeck TR; Trinh QD
    Cancer; 2021 Aug; 127(15):2714-2723. PubMed ID: 33999405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Sutcliffe S; Grubb Iii RL; Platz EA; Ragard LR; Riley TL; Kazin SS; Hayes RB; Hsing AW; Andriole GL;
    BJU Int; 2012 Oct; 110(7):1050-9. PubMed ID: 22429766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Breyer BN; Huang WY; Rabkin CS; Alderete JF; Pakpahan R; Beason TS; Kenfield SA; Mabie J; Ragard L; Wolin KY; Grubb RL; Andriole GL; Sutcliffe S
    BJU Int; 2016 Jan; 117(1):145-54. PubMed ID: 25601300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rural vs. urban disparities in association with lower urinary tract symptoms and benign prostatic hyperplasia in ageing men, NHANES 2001-2008.
    Egan KB; Suh M; Rosen RC; Burnett AL; Ni X; Wong DG; McVary KT
    Int J Clin Pract; 2015 Nov; 69(11):1316-25. PubMed ID: 26215544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship of socioeconomic factors with medical utilization for lower urinary tract symptoms and benign prostatic hyperplasia in a South Korean community].
    Kim HH; Kong KA; Lee HJ; Yoon H; Lee BE; Moon OR; Park H
    J Prev Med Public Health; 2006 Mar; 39(2):141-8. PubMed ID: 16615269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.